Ketanserin pharmacokinetics in patients with renal failure.-Reference-Cited by-同舟云学术

Ketanserin pharmacokinetics in patients with renal failure.

Published:1990-06 Issue:6 Volume:29 Page:715-723
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Barendregt JN,Peer A,Hoeven JG,Oene JC,Tjandra YI

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1990.tb03693.x/fullpdf

Reference14 articles.

1. Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension;Hedner;Br. J. clin. Pharmac.,1983

2. Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administration;Heykants;Eur. J. clin. Pharmac.,1986

3. Pharmacokinetic evaluation of the in vitro and in vivo pharmacological profile of the major metabolites of ketanserin in the rat;Heykants;Arzneimittel.-Forsch. Drug Res.,1988

4. Bioavailability and pharmacokinetics of ketanserin in elderly subjects;Kurowski;Eur. J. clin. Pharmac.,1985

5. Plasma levels, excretion and biotransformation of ketanserin after a single oral dose in rats, dogs and man;Meuldermans;Arch. int. Pharmacodyn.,1985

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and synthesis of a new series of hybrids of functionalised N1-[(1H-1,2,3-triazol-4-yl)methyl]quinazoline-2,4-dione with antiviral activity against Respiratory Syncytial Virus;Antiviral Research;2023-01

2. Implications of Kidney Disease on Metabolic Reduction;Current Drug Metabolism;2016-07-15

3. Reinvestigation of the Synthesis of Ketanserin () and its Hydrochloride Salt () via 3-(2-Chloroethyl)-2,4-(1H,3H)-quinazolinedione () or Dihydro-5H-oxazole(2,3-b)quinazolin-5-one ();Journal of Heterocyclic Chemistry;2013-10-23

4. Ketanserin;xPharm: The Comprehensive Pharmacology Reference;2007

5. Prediction of Pharmacokinetics Prior to In Vivo Studies. 1. Mechanism‐Based Prediction of Volume of Distribution;Journal of Pharmaceutical Sciences;2002-01